Olema Oncology to Participate in Upcoming Investor Conferences in May
01 Maio 2024 - 8:02AM
Olema Pharmaceuticals, Inc. (“Olema”, “Olema Oncology”, Nasdaq:
OLMA), a clinical-stage biopharmaceutical company focused on the
discovery, development, and commercialization of targeted therapies
for women’s cancers, today announced that its management team
will participate in the following upcoming investor conferences:
BofA Securities Health Care Conference
2024Date: Tuesday, May 14, 2024, at 4:35 p.m. PTLocation:
Encore Hotel in Las Vegas, NVFormat: Presentation
H.C. Wainwright 2nd
Annual BioConnect Investor ConferenceDate: Monday,
May 20, 2024, at 4:00 p.m. ETLocation: NASDAQ Headquarters in New
York, NYFormat: Fireside Chat
UBS Spring Biotech SymposiumDate: Tuesday, May
21, 2024Location: New York, NYFormat: One-on-one Meetings
TD Cowen 5th Annual Oncology Innovation
SummitDate: Tuesday, May 28, 2024, at 10:00 a.m.
ETLocation: VirtualFormat: Fireside Chat
Live webcasts of the presentations and any accompanying
materials will be available under the News & Events section of
Olema’s investor relations website at ir.olema.com. The webcasts
will be archived for at least 30 days.
About Olema OncologyOlema Oncology is a
clinical-stage biopharmaceutical company committed to transforming
the standard of care and improving outcomes for women living with
cancer. Olema is advancing a pipeline of novel therapies by
leveraging our deep understanding of endocrine-driven cancers,
nuclear receptors, and mechanisms of acquired resistance. In
addition to our lead product candidate, palazestrant (OP-1250), a
proprietary, orally-available complete estrogen receptor (ER)
antagonist (CERAN) and a selective ER degrader (SERD), Olema is
developing a potent KAT6 inhibitor (OP-3136). Olema is
headquartered in San Francisco and has operations in Cambridge,
Massachusetts. For more information, please visit us at
www.olema.com.
Contact:Geoffrey Mogilner, Vice President, Investor Relations
and Communicationsir@olema.com
Olema Pharmaceuticals (NASDAQ:OLMA)
Gráfico Histórico do Ativo
De Abr 2024 até Mai 2024
Olema Pharmaceuticals (NASDAQ:OLMA)
Gráfico Histórico do Ativo
De Mai 2023 até Mai 2024